Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03305198Completed
Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Changes in the metabolomic signature of arterial claudication at 30 minutes. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03305198.